Back
Gold Royalty Vs. PTC Therapeutics Industry Stock Comparison
Sell
25
GROY
Gold Royalty
Last Price:
1.44
Seasonality Move:
-15.48%
Sell
34
PTCT
PTC Therapeutics
Last Price:
30.92
Seasonality Move:
8.11%
Sell
25
Gold Royalty (GROY)
is a Sell
Is Gold Royalty a Buy, Sell or Hold?
- The current Gold Royalty [GROY] share price is $1.41. The Score for GROY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- GROY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $30.39. The Score for PTCT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GROY Stock Price Chart
What is Gold Royalty's stock price today?
-
The Gold Royalty share price today is $1.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GROY is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $30.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight selling pressure.
GROY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 40.08 | Sell |
| Chaikin Money Flow: | 285692 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.39 - 1.55) | Sell |
| Bollinger Bands (100): | (1.54 - 2) | Sell |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.8 | Sell |
| Relative Strength Index (14 RSI): | 35.32 | Sell |
| Chaikin Money Flow: | -285238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.46 - 37.72) | Sell |
| Bollinger Bands (100): | (26.79 - 35.21) | Sell |
GROY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.39 | Buy |
| 20-day SMA: | 1.45 | Sell |
| 50-day SMA: | 1.7 | Sell |
| 200-day SMA: | 1.58 | Sell |
| 8-day EMA: | 1.4 | Buy |
| 20-day EMA: | 1.47 | Sell |
| 50-day EMA: | 1.62 | Sell |
| 200-day EMA: | 1.7 | Sell |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.66 | Sell |
| 20-day SMA: | 35.43 | Sell |
| 50-day SMA: | 34.01 | Sell |
| 200-day SMA: | 27.58 | Buy |
| 8-day EMA: | 32.88 | Sell |
| 20-day EMA: | 34.35 | Sell |
| 50-day EMA: | 33.7 | Sell |
| 200-day EMA: | 31.8 | Sell |
Gold Royalty Earnings Growth & GROY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.01 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.
Gold Royalty Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||